NJ A973 | 2020-2021 | Regular Session
Note: Carry Over of previous A4273
Note: Carry Over of previous S1756
Note: Carry Over of previous S1756
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 14 2020 - 25% progression, died in committee
Action: 2020-01-14 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Pending: Assembly Financial Institutions and Insurance Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 14 2020 - 25% progression, died in committee
Action: 2020-01-14 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Pending: Assembly Financial Institutions and Insurance Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Requires health benefits coverage for buprenorphine and buprenorphine/naloxone under certain conditions.
Title
Requires health benefits coverage for buprenorphine and buprenorphine/naloxone under certain conditions.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2020-01-14 | Assembly | Introduced, Referred to Assembly Financial Institutions and Insurance Committee |
Same As/Similar To
A4273 (Carry Over) 2018-06-27 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
S1756 (Carry Over) 2018-02-05 - Introduced in the Senate, Referred to Senate Commerce Committee
S1756 (Carry Over) 2018-02-05 - Introduced in the Senate, Referred to Senate Commerce Committee
Subjects
New Jersey State Sources
| Type | Source |
|---|---|
| Summary | https://www.njleg.state.nj.us/bill-search/2020/A973 |
| Text | https://pub.njleg.gov/Bills/2020/A1000/973_I1.HTM |
